FLT1 Antikörper (N-Term)
Kurzübersicht für FLT1 Antikörper (N-Term) (ABIN1740692)
Target
Alle FLT1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- Reacts with the N-terminus part of human VEGFR1
-
Kreuzreaktivität (Details)
- BLAST analysis of the peptide immunogen showed no homology with other human proteins.
-
Aufreinigung
- Antigen affinity purified
-
Immunogen
- Synthetic 15 amino acid peptide from N-terminus of human VEGFR1. Percent identity with other species by BLAST analysis: Human (100%), Gorilla (100%), Gibbon (100%), Monkey (93%), Marmoset (93%), Dog (93%), Panda (93%), Horse (93%), Opossum (93%)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Working dilution: IHC-P (5 - 10 μg/mL)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.14 mg/mL
-
Buffer
- PBS, Sodium azide 0.1 %
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C/-80 °C
-
Informationen zur Lagerung
- Long term: -70°C, Short term: +4°C
-
-
- FLT1 (Fms-Related tyrosine Kinase 1 (VEGFR1) (FLT1))
-
Andere Bezeichnung
- VEGFR1
-
UniProt
- P17948
-
Pathways
- RTK Signalweg, Signaling Events mediated by VEGFR1 and VEGFR2, VEGFR1 Specific Signals
Target
-